Skip to content

Etude de bioéquivalence entre Circadin et Melatonin PILEJE LP 2 mg

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519932-17-00
Acronym
CHAMM / OP113523.PIL
Enrollment
24
Registered
2025-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary insomnia characterized by poor quality of sleep

Interventions

None listed

Sponsors

Pileje
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026